Technology
Health
Biotechnology
IMV
$3.199876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$3.19
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.13 (-3.95%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell IMV and other stocks, options, ETFs, and crypto commission-free!
About IMV
IMV, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the development of cancer immunotherapies and infectious disease vaccines. The firm's patented platform, DepoVax, provides controlled and prolonged exposure of antigens and adjuvant to the immune system. Read More The company was founded by Warwick Kimmins and Brian E. Lowe on March 28, 2000 and is headquartered in Dartmouth, Canada.
CEO
Employees
—
Headquarters
Dartmouth, Nova Scotia
Founded
2000
Market Cap
166.13M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
17.97K
High Today
$3.31
Low Today
$3.15
Open Price
$3.31
Volume
6.46K
52 Week High
$7.07
52 Week Low
$2.69
Collections
Technology
Health
Biotechnology
Medical
Biopharmaceutical
Cancer Prevention
Pharmaceutical
2018 IPO
Price Paid on Robinhood
12% Lower
Right Now
52 Week Low
$2.69
Average Price Paid
$3.64
52 Week High
$7.07
IMV Earnings
-$0.16
-$0.14
-$0.12
-$0.10
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Available Aug 8, After Hours